Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is Rp 17.049.881,76, with a 24-hour trading volume of Rp 31,64T. The asset's market cap is Rp 15,2P, after moving -0.28% in the last day.
Tokenized Eli Lilly And Co is trading at Rp 17.103.947,48, with a tokenized market cap of Rp 95,71B and a 24-hour trading volume of Rp 35,42B. The tokenized asset has moved 0.00% in the past 24 hours.